-
1by T. V. Dubinina, I. Z. Gaidukova, A. A. Godzenko, S. A. Lapshina, A. P. Rebrov, O. A. Rumyantseva, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. I. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. V. Smirnov, A. V. Sitalo, Sh. F. ErdesSubjects: “...asdas...”
Published 2017-09-01
Get full text
Article -
2by E. E. Gubar', A. G. Bochkova, T. V. Dubinina, A. B. Dyomina, O. A. Rumyantseva, M. M. Urumova, S. V. Shubin, A. A. Godzenko, A. V. Smirnov, E. Yu. Tyukhova, S. I. Glukhova, Sh. F. Erdes“... for a period from 3 months to 5 years. BASDAI and ASDAS-CRP were used to assess activity, whereas BASFI...”
Published 2014-10-01
Get full text
Article -
3by E. E. Gubar, T. V. Dubinina, A. D. Demina, O. A. Rumyantseva, M. M. Urumova, S. V. Shubin, A. A. Godzenko, A. V. Smirnov, S. I. Glukhova, Sh. F. Erdes“... criteria. BASDAI and ASDAS C-reactive protein (CRP) values were used to estimate disease activity; BASFI...”
Published 2015-03-01
Get full text
Article -
4by E. E. Gubar, T. V. Dubinina, A. B. Dyomina, O. A. Rumyantseva, S. V. Shubin, A. A. Godzenko, A. V. Smirnov, S. I. Glukhova, M. M. Urumova, Sh. F. Erdes“... criteria. BASDAI and ASDAS-CRP were used to assess activity and functional status was evaluated with BASFI...”
Published 2016-09-01
Get full text
Article -
5by Sh. F. Erdes, T. V. Dubinina, O. A. Rumyantseva, A. B. Dyomina, E. E. Gubar, D. G. Rumyantseva“... of arthritis, enthesitis, BASDAI, ASDAS-CRP, and BASFI. By the end of the 12month follow-up, both groups...”
Published 2016-09-01
Get full text
Article